American Funds Capital Income Builder A (CAIBX) a Zacks Ranked #1 (Strong Buy) was incepted in July 1987 and is managed by Capital Research and Management Company. The objective of CAIBX is to seek above-average current income, a growing stream of income and growth of capital. CAIBX invests at least 50% of assets in equity securities of large, established companies with proven records of increasing dividends. CAIBX also invests in preferred stocks, convertibles, bonds and cash. CAIBX may invest up to 40% of assets in securities of non U.S. issuers. This Large Value product, as of the last filing, allocates their fund in seven major groups; Foreign Stock, Large Value, Foreign Bond, Intermediate Bond, Emerging Market, Large Growth and Precious Metal. Further, as of the last filing, Microsoft Corp, Merck & Co Inc and General Electric Co were the top holdings for CAIBX. American Funds Capital Income Builder A, managed by American Funds, carries an expense ratio of 0.59%. Moreover, CAIBX requires a minimal initial investment of $250. CAIBX has a history of positive total returns for over 10 years. Specifically, the fund’s returns over the 3, 5 year benchmarks; 3 year 5.20% and 5 year 6.45%. To see how this fund performed compared in its category, please click here. CAIBX’s performance, as of the last filing, when compared to funds in its category was in the top 30% in 1 year, top 70% over the past 3 years, and in the 70% over the past 5 years. Zacks Premium To see the Zacks Mutual Fund Rank for the funds you’re interested in —plus, gain access to the Zacks Rank for your stocks and ETFs; Premium Screens; Equity Research Reports; Focus List portfolio of 50-longer-term stocks and more— start your 30-day free trial to Zacks Premium. View All Zacks #1 Ranked Mutual FundsWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Get Your Free (CAIBX): Fund Analysis Report To read this article on Zacks.com click here. Zacks Investment Research